ACROBiosystems
Biotechnology ResearchDelaware, United States51-200 Employees
ACROBiosystems develops and supplies recombinant proteins, antibodies, kits, and related scientific services to support biopharmaceutical research and development, backed by a stringent quality control framework. Its customer base includes leading pharmaceutical companies and academic institutions, for whom it supports discovery, screening, development, preclinical work, and clinical applications. Founded in 2010 and listed in 2021, the company is headquartered in Newark, Delaware, and operates a global network of offices, R&D centers, and production sites in cities across the United States, Europe, and China. ACROBiosystems works through multiple subsidiaries and brands and has established long-standing partnerships with major industry players such as Pfizer, Novartis, and Johnson & Johnson. In May 2026, the firm announced a global license solution upgrade for HEK293 functional cell lines to streamline regulatory compliance and accelerate biopharmaceutical research and development.
1-888-653-2347 
support@leadiq.com 
